By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market Thursday that its fourth-quarter revenues increased 8 percent, and 10 percent on a currency-neutral basis, led by a double-digit gain for its Clinical Diagnostics segment.

The Hercules, Calif.-based firm brought in total revenues of $533.7 million for the three-month period ended Dec. 31, compared to $495.1 million for Q4 2009. It easily beat analysts' consensus estimate of $514.5 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.